For Healthcare Professionals

RELIEF - A Global Registry to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain

clipboard-pencil

About the study

To compile characteristics of real-world clinical outcomes for Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice, when used according to the applicable Directions for Use - and - To evaluate the economic value and technical performance of Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice
user-3

Who can take part

You may be eligible to participate in the study if you meet the following criteria:

INCLUSION CRITERIA

Key Inclusion Criteria:

  1. Study candidate is scheduled to be trialed, on-label, with a commercially approved Boston Scientific neurostimulation system for pain, per local directions for use
  2. Signed a valid, IRB/EC-approved informed consent form
  3. 18 years of age or older

EXCLUSION CRITERIA

Key Exclusion Criteria:

  1. Contraindicated for Boston Scientific neurostimulation system
  2. Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or to complete study assessments
pin location

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply


Contact the study center to learn if this study is a good match for you.
Phone iconCall 855-213-9890Email iconEmail Study Center

Study Details


Contition

Pain

Age

18+

Participants Needed

4800

Est. Completion Date

Oct 31, 2027

Treatment Type

OBSERVATIONAL


Sponsor

Boston Scientific Corporation

ClinicalTrials.gov NCT Identifier

NCT01719055

Study Number

A7007

Understanding Clinical Trials


Get answers to your questions about clinical trials.What is clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?
Vector

Interested?

Sign up to create a personal profile and 
receive news, resources, and alerts 
about clinical trials related to your conditions of interest.